Roman Tiraspolsky/Dreamstime
© Roman Tiraspolsky Dreamstime

US Baby Formula Plant Again Halts Production Due to Flooding

June 17, 2022
In a statement Wednesday, the manufacturer assured consumers that it had "ample existing supply" of most of its specialty formulas to meet demand until production could resume again.

Abbott Nutrition has once again shut down a baby formula plant, this time due to heavy rains and flooding, less than two weeks after it reopened to try and mitigate a crippling U.S. shortage.

The facility in Sturgis, Michigan resumed production on June 4, only to close down again earlier this week so the company could assess rain damage.

Severe thunderstorms that battered southwestern Michigan on Monday resulted in "high winds, hail, power outages and flood damage," as well as "flooding in parts of the city, including areas of our plant," Abbott said in a statement posted to their website Wednesday night.

"As a result, Abbott has stopped production of its EleCare specialty formula that was underway to assess damage caused by the storm and clean and re-sanitize the plant," the statement said.

"This will likely delay production and distribution of new product for a few weeks."

The plant, a major producer of formula, shut down in February and issued a product recall after the death of two babies raised concerns over contamination.

That worsened to a widespread forumula shortage caused by supply issues, which was particularly concerning to parents of infants with allergies or with certain metabolic conditions, who desperately scoured stores and online sources for the specialized formulas.

The crisis prompted President Joe Biden last month to bring in formula from Europe on commercial planes contracted by the U.S. military. He also invoked the Defense Production Act to give baby formula manufacturers first priority in supplies.

Abbott, which controls about 40 percent of the U.S. baby food market, had announced its hypoallergenic EleCare formula and should be back on store shelves around June 20.

In the statement Wednesday, the manufacturer assured consumers that it had "ample existing supply" of EleCare and most of its other specialty formulas to meet demand until production could resume again.

The formula shortage, coming at a time when soaring inflation and supply-chain delays have fanned a growing sense of unease among many American families, and Biden critics have seized on the situation to question the competence of his administration.

Copyright 2022, Agence France-Presse

Popular Sponsored Recommendations

Global Supply Chain Readiness Report: The Pandemic and Beyond

Sept. 23, 2022
Jabil and IndustryWeek look into how manufacturers are responding to supply chain woes.

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

How Organizations Connect and Engage with Frontline Workers

June 14, 2023
Nearly 80% of the 2.7 billion workers across manufacturing, construction, healthcare, transportation, agriculture, hospitality, and education are frontline. Learn best practices...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!